Human testing of Spicogen COVID-19 vaccine to begin in Iran
(Payvand Iran News)

The second and third phases of clinical studies of the Iranian-Australian Spicogen vaccine for coronavirus will be performed in Iran, Iranian Food and Drug Administration spokesman Kianoush Jahanpour said. The first phase of the clinical trial was performed on volunteer Australians and the two next phases will be administrated to 400 Iranians, he stated.